Public Company News

Promising 2-year updated data from cadonilimab presented at 2023 ASCO highlighting promising efficacy in PD-L1-negative patients

HONG KONG, June 6, 2023 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso") released two-year updated data from a Phase Ib/II clinical study of cadonilimab – a first-in-class PD-1/CTLA-4 bispecific antibody developed by Akeso – in combination with chemotherapy as first-line therapy for advanced gastr...

2023-06-06 19:04 3017

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

- Marking the first phase of the company's second Bio Campus, Plant 5 is expected to have shortest construction timeline - Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant - Key features of Plant 5 include seamless ...

2023-06-06 19:00 3286

Altair Global Survey Reveals Significant Opportunities to Improve Efficiency, Scale, and Success of Enterprise AI and Data Projects

Survey identifies opportunities to remove organizational, technological, and financialfriction       TROY, Mich., June 6, 2023 /PRNewswire/ -- Altair (NASDAQ: ALTR), a global leader in computational science and artificial intelligence (AI), released results from an international survey which rev...

2023-06-06 19:00 3082

Golden Heaven Group Holdings Ltd. Achieves an Approximately 30% Year-over-Year Traffic Growth During China's Labor Day Holiday

NANPING, China, June 6, 2023 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, announced today that its six amusement parks host a total of approximately 35,000 visitors duringChina's Labor Day holiday from Apr...

2023-06-06 19:00 3909

ChipMOS to Present at Yuanta's 2023 Q2 INVESTMENT FORUM

HSINCHU, June 6, 2023 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"), ...

2023-06-06 18:00 4041

EZGO Announces $8.5 Million Registered Direct Offering

CHANGZHOU, China, June 6, 2023 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a leading short-distance transportation solutions provider inChina, today announced that it has entered into a definitive securities purchase agreement, dated as ofJune 5, 2023 (the "P...

2023-06-06 18:00 4102

New Oriental Extends Share Repurchase Program

BEIJING, June 6, 2023 /PRNewswire/ -- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that its board of directors has authorized the Company to extend its share repurch...

2023-06-06 17:00 2899

36Kr Holdings Inc. Reports First Quarter 2023 Unaudited Financial Results

BEIJING, June 6, 2023 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company" or "We") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2023. ...

2023-06-06 17:00 4130

Manufacturers gambling competitive advantage with slow digital investments and lack of ROI

* Manufacturers with optimized digital transformation (DX) saw profits increase 40% vs. less digitally mature organizations.  * Only 26% of manufacturers surveyed are pursuing new revenue streams; while only 28% are engaging with new ecosystems.  * Biggest ROI gains come from developing new ...

2023-06-06 16:37 2740

Midea Healthcare Unveils New Solutions for Smart Healthcare Market

FOSHAN, China, June 6, 2023 /PRNewswire/ -- Midea Healthcare, as one of primarily business for Midea Group (000333.SZ), recently held a new product launch event in CMEF 2023 with its five medical industry consortia – Wandong (WDM), KUKA, Midea Biomedical, Swisslog Healthcare, and Midea Building ...

2023-06-06 16:10 5210

Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2023

BEIJING, June 6, 2023 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading mobile social and entertainment platform in China, today announced its unaudited financial results for the first quarter of 2023.    First Quarter of 2023 Highlights * Net revenues...

2023-06-06 15:30 4184

Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC

SUZHOU, China and ROCKVILLE, Md., June 6, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that for the second consecutive year, it has release...

2023-06-06 12:20 4339

IBM to Build its First European Quantum Data Center to Serve Expanding Ecosystem

The IBM facility in Ehningen, Germany, expected to open in 2024 IBM Quantum to allow European cloud region users to provision quantum systems and process data within the EU ARMONK, N.Y. and EHNINGEN, Germany, June 6, 2023 /PRNewswire/ -- Today, IBM (NYSE:IBM )...

2023-06-06 12:00 5158

USANA Malaysia Named Top Combination Dietary Supplements Brand by Euromonitor International

USANA Malaysia awarded for fifth year in a row KUALA LUMPUR, Malaysia, June 6, 2023 /PRNewswire/ -- USANA Malaysia was recently awarded the title Top #1 Combination Dietary Supplements Brand in Malaysia by market research giant Euromonitor International—earning this elite recognition for the fift...

2023-06-06 11:00 7028

Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential

SUZHOU, China and ROCKVILLE, Md,, June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released preliminary results from a Phas...

2023-06-06 10:45 3103

Roborock Unveils the Home Cleaning Center: Pioneering a New Era of Immaculate Homes and Enhanced Well-being

BEIJING, June 6, 2023 /PRNewswire/ -- On June 1st, Roborock (688169.SH) officially announced Mr.Xiao Zhan as Roborock Global Brand Ambassador and unveiled the highly anticipated Roborock Home Cleaning Center. The state-of-the-art center seamlessly integrates Roborock's three flagship products—sw...

2023-06-06 10:00 5357

Alphamab Oncology updated clinical research data for KN026 in Combination with KN046 in HER2-Positive Solid Tumors at the ASCO 2023 annual meeting

* As of November 10, 2022, 26 patients with HER2-positive unresectable or metastatic solid tumors (other than breast cancer and gastric/gastroesophageal junction cancer) were enrolled, 92.3% of whom had received ≥2L prior systemic therapy. The objective response rate (ORR) was 53.8% with 6.8 mo...

2023-06-06 09:06 3396

Telix to Present at Jefferies Healthcare Conference

MELBOURNE, Australia, June 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that DrChristian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies Healthcare Conference being held inNew York from June 7 to June 9, 2023...

2023-06-06 08:40 3179

Transcenta Presents Updated Data of Osemitamab (TST001) in Combination with CAPOX as a First-Line Treatment of G/GEJ Cancer at 2023 ASCO Annual Meeting

SUZHOU, China, June 6, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, has presented updated data of C...

2023-06-06 08:20 4284

Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-06-06 08:00 6214